Peak Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2015
For the six months, the company reported revenue was $382,292. Net loss was $1,405,296 against $862,374 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.75 USD | -6.25% | -6.25% | +116.76% |
1st Jan change | Capi. | |
---|---|---|
+116.76% | 7.85Cr | |
+12.71% | 3,15000Cr | |
+10.98% | 8.76TCr | |
+8.10% | 8.07TCr | |
-16.04% | 5.28TCr | |
+35.76% | 5.19TCr | |
+30.86% | 4.61TCr | |
-31.32% | 4.25TCr | |
+78.94% | 4.16TCr | |
+2.37% | 2.82TCr |